Revefenacin for the treatment of chronic obstructive pulmonary disease

Expert Review of Clinical Pharmacology
Fuyuan Li, Junyi Yang

Abstract

Acetylcholine is the predominant parasympathetic neurotransmitter in the airways, and plays a key role in the pathophysiology of chronic obstructive pulmonary disease (COPD). Muscarinic receptors are found in smooth muscle cells and submucosal glands. Binding of acetylcholine to muscarinic receptors could trigger bronchoconstriction. Muscarinic antagonists prevent acetylcholine from binding to its receptors and produce bronchodilation. Revefenacin is the first once-daily dosed nebulized long-acting muscarinic antagonist indicated for the maintenance treatment of patients with COPD. Areas covered: In this paper, the chemical properties, mechanism of action, pharmacokinetics, clinical efficacy and safety of Revefenacin was introduced, and the evolution of muscarinic antagonists is also briefly described. Expert commentary: Revefenacin is a new M3 muscarinic receptor antagonist, which could prevent acetylcholine from binding with the muscarinic receptor, making bronchodilation and relieving COPD symptoms. Revefenacin has a rapid onset of action, and the curative effect is to maintain a long time. Clinical trials showed that Revefenacin could significantly increase forced expiratory volume in 1 s (FEV1) in patients with COPD and im...Continue Reading

References

Jan 1, 1993·Life Sciences·B DisseR Hammer
Mar 2, 2002·The European Respiratory Journal·W VinckenUNKNOWN Dutch/Belgian Tiotropium Study Group
Aug 28, 2009·The Journal of Pharmacology and Experimental Therapeutics·Amadeu GavaldàJorge Beleta
Jun 21, 2011·Trends in Pharmacological Sciences·Maria Gabriella MateraMario Cazzola
Jan 10, 2012·Handbook of Experimental Pharmacology·Kalmia S Buels, Allison D Fryer
Feb 1, 2012·Journal of Allergy·Saeed Kolahian, Reinoud Gosens
Feb 9, 2012·Lancet·Marc DecramerMarc Miravitlles
Feb 24, 2012·Nature·Andrew C KruseBrian K Kobilka
Mar 24, 2012·The European Respiratory Journal·Paul W JonesEsther Garcia Gil
Oct 11, 2012·Drugs·James E Frampton
Feb 9, 2013·American Journal of Respiratory and Critical Care Medicine·Wen Qi GanMichael Brauer
Jun 12, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Donald A MahlerAlex H Gifford
May 21, 2014·NPJ Primary Care Respiratory Medicine·Thierry TroostersCarla Yunis
Jun 15, 2014·Pulmonary Pharmacology & Therapeutics·Amadeu GavaldàMontserrat Miralpeix
Dec 17, 2014·Trends in Pharmacological Sciences·Loes E M Kistemaker, Reinoud Gosens
Jan 7, 2015·American Journal of Respiratory and Critical Care Medicine·Laura M PaulinUNKNOWN SPIROMICS Research Group
Jan 13, 2016·Drugs·Roy A PleasantsJames F Donohue
Nov 2, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Donald P Tashkin
Dec 23, 2016·Expert Opinion on Investigational Drugs·Mark A MastrodicasaMuhammad A Zafar
Apr 27, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Mònica MonteagudoMarc Miravitlles
May 12, 2017·Therapeutic Advances in Chronic Disease·Kesavan Suresh Babu, Jaymin Bhagwanji Morjaria
Nov 29, 2017·Drug Design, Development and Therapy·Pierachille SantusMaurizio Rizzi
Jun 22, 2018·International Journal of Chronic Obstructive Pulmonary Disease·Donald P Tashkin, Nicholas J Gross
Aug 18, 2018·The European Respiratory Journal·Reinoud Gosens, Nicholas Gross
Nov 22, 2018·Current Opinion in Pulmonary Medicine·Robert M Burkes, Michael B Drummond

❮ Previous
Next ❯

Citations

Dec 14, 2019·COPD·Chitra Lal, Akram Khan
Apr 26, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Astrid BaclePascal Le Corre
Apr 28, 2020·Journal of Medicinal Chemistry·Andrew C FlickChristopher J O'Donnell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Respiratory Medicine
Gian Galeazzo Riario-SforzaCristoforo Incorvaia
The European Respiratory Journal
Reinoud Gosens, Nicholas J Gross
International Journal of Chronic Obstructive Pulmonary Disease
Paschalis SteiropoulosDemosthenes Bouros
© 2022 Meta ULC. All rights reserved